These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24621146)

  • 21. Woman With Polycystic Kidney Disease: The Role of Precision Medicine in Hypertension Management.
    Clark D; Dominiczak AF; Touyz RM; Barigou M; Zoghby Z; Jones DW
    Hypertension; 2020 Nov; 76(5):1332-1338. PubMed ID: 32951469
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatable complications in undiagnosed cases of autosomal dominant polycystic kidney disease.
    Ravine D; Walker RG; Gibson RN; Sheffield LJ; Kincaid-Smith P; Danks DM
    Lancet; 1991 Jan; 337(8734):127-9. PubMed ID: 1670785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure control key in polycystic kidney disease.
    Shields J; Maxwell AP
    Practitioner; 2008 Feb; 252(1703):22, 25-6, 29. PubMed ID: 18426156
    [No Abstract]   [Full Text] [Related]  

  • 24. Tuberous sclerosis complex with polycystic kidney disease of the adult type: the TSC2/ADPKD1 contiguous gene syndrome.
    Bisceglia M; Galliani C; Carosi I; Simeone A; Ben-Dor D
    Int J Surg Pathol; 2008 Oct; 16(4):375-85. PubMed ID: 18611938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathophysiological basis of renal nerve ablation for the treatment of hypertension.
    Ziakas A; Gossios T; Doumas M; Karali K; Megarisiotou A; Stiliadis I
    Curr Vasc Pharmacol; 2014 Jan; 12(1):23-9. PubMed ID: 23905601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient.
    Di Daniele N; De Francesco M; Violo L; Spinelli A; Simonetti G
    Nephrol Dial Transplant; 2012 Apr; 27(4):1689-90. PubMed ID: 22467751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease.
    Saggar-Malik AK; Afzal AR; Swissman JS; Bland M; Sagnella GA; Eastwood JB; MacGregor GA; Jeffery S
    Genet Test; 2000; 4(3):299-303. PubMed ID: 11142763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns.
    Faselis C; Doumas M; Kokkinos P; Tsioufis C; Papademetriou V
    Curr Vasc Pharmacol; 2014 Jan; 12(1):38-46. PubMed ID: 23905598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years.
    Milutinovic J; Fialkow PJ; Agodoa LY; Phillips LA; Rudd TG; Sutherland S
    Am J Kidney Dis; 1990 Mar; 15(3):237-43. PubMed ID: 2137671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
    Cerasola G; Vecchi M; Mulè G; Cottone S; Mangano MT; Andronico G; Contorno A; Parrino I; Renda F; Pavone G
    Am J Nephrol; 1998; 18(5):391-8. PubMed ID: 9730562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrocalcinosis in a child with autosomal dominant polycystic kidney disease and a prolapsing ectopic ureterocele.
    Burton EM; Hanna JD; Mercado-Deane MG
    Pediatr Radiol; 1995; 25(6):462-5. PubMed ID: 7491203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unsuspected atherosclerotic renal artery stenosis causing renal failure in a patient with adult polycystic kidney disease.
    Makanjuola D; Reidy J; Scoble JE
    Nephrol Dial Transplant; 1997 Mar; 12(3):591-2. PubMed ID: 9075150
    [No Abstract]   [Full Text] [Related]  

  • 33. Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease.
    Milutinovic J; Fialkow PJ; Agodoa LY; Phillips LA; Bryant JI
    Obstet Gynecol; 1983 May; 61(5):566-70. PubMed ID: 6835610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy in a patient with autosomal-dominant polycystic kidney disease and congenital hepatic fibrosis.
    Klinkert J; Koopman MG; Wolf H
    Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):45-7. PubMed ID: 9481546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress on renal sympathetic nerve activity and catheter renal sympathetic denervation in hypertension].
    Wang P; Du X; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):569-70. PubMed ID: 21033143
    [No Abstract]   [Full Text] [Related]  

  • 36. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.
    Brinkmann J; Heusser K; Schmidt BM; Menne J; Klein G; Bauersachs J; Haller H; Sweep FC; Diedrich A; Jordan J; Tank J
    Hypertension; 2012 Dec; 60(6):1485-90. PubMed ID: 23045466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Functional state of the arteries in polycystosis of the kidney].
    Zelinskiĭ BA
    Kardiologiia; 1969 Dec; 9(12):119-21. PubMed ID: 5383784
    [No Abstract]   [Full Text] [Related]  

  • 38. Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation.
    Tank J; Heusser K; Brinkmann J; Schmidt BM; Menne J; Bauersachs J; Haller H; Diedrich A; Jordan J
    J Am Soc Hypertens; 2015 Oct; 9(10):794-801. PubMed ID: 26324745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous coronary dissection in polycystic kidney disease.
    Afari ME; Quddus A; Bhattarai M; John AR; Broderick RJ
    R I Med J (2013); 2013 Dec; 96(12):44-5. PubMed ID: 24303518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of polycystic kidney disease with nephrotic syndrome.
    Nakahama H; Inoue T; Kakihara M; Takama T; Mikami H; Orita Y; Kamada T
    Urol Int; 1991; 46(1):77-8. PubMed ID: 2024380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.